Cargando…
Astrocytoma progression scoring system based on the WHO 2016 criteria
Diffuse astrocytoma (including glioblastoma) is morbid with a worse prognosis than other types of glioma. Therefore, we sought to build a progression-associated score to improve malignancy and prognostic predictions for astrocytoma. The astrocytoma progression (AP) score was constructed through bioi...
Autores principales: | Li, Zhen-Hang, Guan, Yan-Lei, Liu, Qiang, Wang, Yao, Cui, Run, Wang, Yun-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331604/ https://www.ncbi.nlm.nih.gov/pubmed/30643174 http://dx.doi.org/10.1038/s41598-018-36471-4 |
Ejemplares similares
-
Expression of delta-catenin is associated with progression of human astrocytoma
por: MingHao, Wang, et al.
Publicado: (2011) -
The 2016 WHO versus 2008 WHO Criteria for the Diagnosis of Chronic Myelomonocytic Leukemia
por: Moon, Yeonsook, et al.
Publicado: (2018) -
The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population
por: Gareton, Albane, et al.
Publicado: (2019) -
Long-term molecular changes in WHO grade II astrocytomas following radiotherapy
por: Yue, Wei-Ying, et al.
Publicado: (2012) -
EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas
por: Tsai, Wen-Chiuan, et al.
Publicado: (2013)